Metformin Hydrochloride

็›้…ธไบŒ็”ฒๅŒ่ƒ

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameMetformin Hydrochloride
Drug Alias NameMetformin Delayed-Release็›้…ธไบŒ็”ฒๅ››ๅŒ่ƒMetformin DR็”ฒ็ฆๆ˜ŽไบŒ็”ฒๅŒ่ƒ็›้…ธไบŒ็”ฒๅŒ่ƒ +[32]ย 
ClassificationSmall molecules
Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Metastatic breast cancerPosterior Fossa Ependymal Tumor +[158]ย 
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryFrance
Original Approved Date1957/01/01
Country/TerritoryCzechiaBelgiumBosnia and Herzegovina +[55]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBadr UniversityUtah State UniversityInstituto Nacional De Ciencias Medicas Y Nutricion Salvador Zubiran +[86]ย 
Inactive CompaniesDana-Farber Cancer InstituteCanadian Institutes Of Health Research (Cihr)Sandoz +[89]ย 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Posterior Fossa Ependymal TumorCastration-Sensitive Prostate Neoplasms +[107]ย 
Inactive IndicationsMetastatic breast cancerAutism Spectrum DisorderBipolar Disorder +[51]ย 

Other Information

ATC CodeA10BA02
Related LinksWikipediaDrugBankKEGG